Canada Ophthalmic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Canada Ophthalmology Drugs & Devices Market is segmented By Product (Drugs and Devices ), and Disease

Market Snapshot

Canada Ophthalmic Drugs & Devices  Devices & Drugs Market
Study Period: 2018 - 2026
Base Year: 2019
CAGR: 2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The CanadaOphthalmology Drugs & Devices Market is expected to grow with a CAGR of 2% during the forecasted period. Certain factors that are driving the growth of the market include demographic shift, the impact of the prevalence of eye disease, technological advancements in the field of ophthalmology, and the rising geriatric population. The aging population is expected to burden all areas of healthcare, and ophthalmologists provide approximately 90% of their procedure-based services to seniors. In Canada, the leading cause of visual impairment is glaucoma, diabetic retinopathy, degenerative myopia, age-related macular degeneration, and cataract. In addition, according to the Global Health Data Exchange, the prevalence of age-related macular degeneration is around 18,644 in 2018. The number is estimated to grow by 19,252 in 2019. Hence, the rising prevalence of eye disorders will lead to the growing demand for drugs and devices for diagnosis and treatment.

Scope of the report

As per the scope of the report, ophthalmology devices are the equipment that are used for the diagnosis and treatment of various ophthalmic diseases, such as cataract, glaucoma, and refractive errors. Ophthalmic drugs are used to treat eye infections and some of the above-mentioned diseases. The drugs covered in the report are glaucoma drugs, retinal disorder drugs, dry eye disease drugs, drugs for infections, and other drugs

By Product
Devices
Surgical Devices
Intraocular Lenses
Ophthalmic Lasers
Other Surgical Devices
Diagnostic Devices
Drugs
Glaucoma Drugs
Retinal Disorder Drugs
Dry Eye Drugs
Allergic Conjunctivitis and Inflammation Drugs
Other Drugs
By Disease
Glaucoma
Cataract
Age-Related Macular Degeneration
Inflammatory Diseases
Refractive Disorders
Other Diseases

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cataract Segment is Expected to Show Better Growth in the Forecast Years

Based on disease, the market is segmented into glaucoma, cataract, age-related macular degeneration, inflammatory diseases, refractive disorders and other diseases. As per the Global Health Data Exchange, it is estimated that the prevalence of cataract in Canada is 193,707 in 2018. It is further increased by 197,442 in 2019. Cataract surgery remains the most effective way to help restore vision for people with cataracts. Hence, with the rising burden of eye disease in Japan, the market is expected to grow in the forecast period.

key trend canada drug.png

Competitive Landscape

The Canada Ophthalmology Drugs & Devices Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Essilor International SA, Johnson & Johnson, Nidek Co. Ltd, Topcon Corporation, Ziemer Group AG

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Demographic Shift and Impact of Prevalence of Eye Disease

      2. 4.2.2 Technological Advancements in the Field of Ophthalmology

    3. 4.3 Market Restraints

      1. 4.3.1 Higher Cost of the Ophthalmic Devices and Treatment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Devices

        1. 5.1.1.1 Surgical Devices

          1. 5.1.1.1.1 Intraocular Lenses

          2. 5.1.1.1.2 Ophthalmic Lasers

          3. 5.1.1.1.3 Other Surgical Devices

        2. 5.1.1.2 Diagnostic Devices

      2. 5.1.2 Drugs

        1. 5.1.2.1 Glaucoma Drugs

        2. 5.1.2.2 Retinal Disorder Drugs

        3. 5.1.2.3 Dry Eye Drugs

        4. 5.1.2.4 Allergic Conjunctivitis and Inflammation Drugs

        5. 5.1.2.5 Other Drugs

    2. 5.2 By Disease

      1. 5.2.1 Glaucoma

      2. 5.2.2 Cataract

      3. 5.2.3 Age-Related Macular Degeneration

      4. 5.2.4 Inflammatory Diseases

      5. 5.2.5 Refractive Disorders

      6. 5.2.6 Other Diseases

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Alcon Inc.

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 Carl Zeiss Meditec AG

      4. 6.1.4 Essilor International SA

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Nidek Co. Ltd

      7. 6.1.7 Topcon Corporation

      8. 6.1.8 Ziemer Group AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Canada Ophthalmology Drugs & Devices Market market is studied from 2018 - 2026.

The Canada Ophthalmology Drugs & Devices Market is growing at a CAGR of 2% over the next 5 years.

Alcon Inc., Bausch Health Companies Inc, Carl Zeiss Meditec AG, Johnson & Johnson, Nidek Co. Ltd are the major companies operating in Canada Ophthalmology Drugs & Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!